Safety, Tolerability, and Immunogenicity of a Recombinant Nonavalent Human Papillomavirus Vaccine (Escherichia coli) in Healthy Chinese Women Aged 18–45 Years: A Phase 1 Clinical Trial
Mingwei Wei(Jiangsu Provincial Center for Disease Control and Prevention), Yongjiang Liu(Collaborative Innovation Center of Advanced Microstructures), Jingxin Li(Jiangsu Provincial Center for Disease Control and Prevention), Weiwei Han(Nanjing Medical University), Jing Zhang(Children's Hospital of Fudan University), Huilong Yu(Beijing Red Cross Blood Center)
Cited by 2
Related Papers
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|977
An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China
|Virology Journal|2010|473
MicroRNA identification based on sequence and structure alignment
|Bioinformatics|2005|287